Zaki Sellam, Msc, Mba
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
Redpoint Research
Norway
Biography
As a founder of ESN Life Sciences GmbH (specialized consulting boutique in Basel, Switzerland), he has supported several innovative biotech start-up from their creation & structuration to their financing & partnering activities. One instance is the 3 years deep support to OriBase Pharma (Oncology Biotech Start-up) resulting in a large transaction of several digit millions, hence securing the firm financing up to commercialization of its products.
Research Interest
Meanwhile, he co-founded various promising Biotech ventures such as Avicenna Oncology GmbH (Antibody Drug Conjugate field, Basel, Switzerland), CarboMimetics SAS (GlycoChemistry field, Paris, France), Atfal Pharma AG (Paediatrics field, Basel, Switzerland) & Genius Therapeutics SAS (Immuno-Oncology field, Bordeaux, France). Zaki could successfully secure the seed financing and several tech transfer transactions for these ventures.
